| Name: |
Eritrogen (Erythropoietin) Injection BP |
|
| Company: |
FEROZSONS LABORATORIES LIMITED |
|
| Therapeutic Segment: |
Bioscience product, glycoprotein product |
|
| Area: |
Anemia due to Chronic Kidney Disease, Chemotherapy and Nephropathic Diabetes |
|
|
|
| Eritrogen is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid progenitors in the bone marrow. Eritrogen (Erythropoietin), a 165 amino acid glycoprotein manufactured by recombinant DNA technology, has the same biological effects as endogenous erythropoietin. It has a molecular weight of 30,400 Daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced. The product contains the identical amino acid sequence of isolated natural erythropoietin.
|
English 
اردو 
